Ad-hoc | 24 May 2002 14:36

Capital Stage AG english

Capital Stage AG: Provisional group result for 2001 Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Capital Stage realises earnings of 7.63 million euros through sale of stake / provisional group result for 2001 +++ Capital Stage AG has disposed of half its 17.70 stake in farmatic biotech energy ag, Nortorf. The earnings from this are 7.63 million euros. According to provisional figures, Capital Stage closed 2001 with a consolidated post-tax result of -7.85 million euros (previous year: +1,39 million euros) and group earnings of 17.13 million euros (previous year: 13.25 million euros). The result includes non-recurring special expenses of around 3 million euros in connection with the incorporation of the business activities of Futura Capitalis AG and with restructuring measures in autumn. Unforeseen value adjustments of assets of 6.8 million euros also strained the result. The group made a profit of 1.24 million euros (previous year: +1.35 million euros) before interest, taxes, depreciation and amortisation. The provisional DVFA result is -0.34 euros following +0.02 euros (adjusted for splitting) in 2000. With the contribution of the subsidiaries and participating interests of Futura Capitalis AG per 31st July 2001, the Investments division assumed a central role within the group. This division made an EBIT of +5.12 million euros through the sale of shares in companies. The value of the investment portfolio was adjusted by 0.67 million euros. Depreciation of 11.6 million euros on the contributed Futura Capitalis participating interests before incorporation in the group did not affect the consolidated result. The Services division newly created as part of the merger contributed to the groups result with an EBIT of +0.15 million. The Banking business division, which essentially comprises the range of services of the former HWAG, closed the year with an EBIT of – 12.67 million euros. Capital Stage regards itself as being well-positioned as a result of the cost- cutting and restructuring measures it has initiated and the revaluation of the portfolio. As a result of the sales of the stake in farmatic, a balanced consolidated result for 2002 is expected, even given no change in the difficult market conditions. end of ad-hoc-announcement (c)DGAP 24.05.2002 Issuer’s information/explanatory remarks concerning this ad-hoc-announcement: The definitive figures for 2001 and the first quarter of 2002 will be published at http://www.capitalstage.com on 31st May 2002. Contact: Dorothee Timm / head of IR, Domstraße 17, Capital Stage AG, D-20095 Hamburg, phone: +49 (0)40. 37 85 62 620, fax: +49 (0)40. 37 85 62 611, dorothee.timm@capitalstage.com, http://www.capitalstage.com ——————————————————————————– WKN: 609500; ISIN: DE0006095003; Index: SDax Listed: Geregelter Markt in Frankfurt (SMAX) und Hamburg; Freiverkehr in Berlin, Düsseldorf und Stuttgart 241436 Mai 02